Schedule 13D ownership disclosure
CLARUS THERAPEUTICS HXXXBANKRUPTCY EFF 030123
Security class unavailable · CUSIP: 18271L107
Event date: 2021-09-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 25.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-354079
- Form type
- SC 13D
- Filer
- Clarus Therapeutics Holdings, Inc.
- CIK
- CIK 1817944
- Filed
- Dec 10, 2021
- Reporting period
- Sep 09, 2021
- Description
- Schedule 13D beneficial ownership